undamentalytics Newsletter
Sign in

Vertex Pharmaceuticals number of employees

Vertex Pharmaceuticals reported 6,400 employees at December 31, 2025 in its latest annual report, up 300 (4.9%) on the year before. That compares with 3,900 at December 31, 2021. Revenue per employee was $1.9m.

Headcount by year

Fiscal year endEmployeesChangeRevenue per employeeSource
December 31, 2025 6,400 +300 (4.9%) $1.9m 10-K, filed February 13, 2026
December 31, 2024 6,100 +700 (13.0%) $1.8m 10-K, filed February 13, 2025
December 31, 2023 5,400 +600 (12.5%) $1.8m 10-K, filed February 15, 2024
December 31, 2022 4,800 +900 (23.1%) $1.9m 10-K, filed February 10, 2023
December 31, 2021 3,900 — $1.9m 10-K, filed February 9, 2022

What the annual reports say

  • Furthermore, the extent of government regulation, which might result from future legislation or administrative action, cannot accurately be predicted. 21 EMPLOYEES AND HUMAN CAPITAL MANAGEMENT As of December 31, 2025 , we had approximately 6,400 employees. 2025 annual report
  • EMPLOYEES AND HUMAN CAPITAL MANAGEMENT As of December 31, 2024, we had approximately 6,100 employees. 2024 annual report
  • EMPLOYEES AND HUMAN CAPITAL MANAGEMENT As of December 31, 2023, we had approximately 5,400 employees. 2023 annual report
  • EMPLOYEES AND HUMAN CAPITAL MANAGEMENT As of December 31, 2022, we had approximately 4,800 employees. 2022 annual report
  • Even with these measures, however, we cannot guarantee compliance with the various complex laws and regulations to which we are subject now or in the future. 22 EMPLOYEES AND HUMAN CAPITAL MANAGEMENT As of December 31, 2021, we had approximately 3,900 employees. 2021 annual report

Headcount as the company states it in Item 1 of its annual report (some count full-time equivalents or exclude part-time and temporary staff), at the date it gives. Years where the report states no clear total are left out rather than estimated. Changes can reflect acquisitions and disposals as well as hiring and job cuts.

Compare with peers

Head to head: BIIB vs VRTXREGN vs VRTXINCY vs VRTX

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Vertex Pharmaceuticals's SEC filings (10-K and 10-Q), retrieved October 20, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Vertex Pharmaceuticals.